Emerging Issues in Pathogenesis, Adaptive Immunity, and Vertical Transmission of HCV and HIV-1

Hugo Soudeyns, PhD
Director, Department of Microbiology, Infectious Diseases and Immunology
Faculty of Medicine, University of Montreal

Dr. Hugo Soudeyns trained in virology under the supervision of Dr. Mark A. Wainberg (1987‐1993), with whom he characterized the properties of antiviral drug lamivudine (3TC). He also spent time in the labs of Dr. Rafick Sekaly (1994‐1997), Dr. Anthony Fauci (NIH; Bethesda; 1994‐1995), and Giuseppe Pantaleo (CHUV; Lausanne, Switzerland; 1996-1999), where he worked on the pathogenesis of acute HIV infection. In January 2000, Dr. Soudeyns opened a research unit devoted to the study of viral immunopathology at CHU Sainte‐Justine, Montreal, the most important pediatric hospital in Eastern Canada. Pursued in collaboration with CHU Sainte‐ Justine’s Centre maternel et infantile sur le sida, the work of Dr. Soudeyns led to the identification of important differences in cell‐mediated immunity between adults and children, and contributed to the understanding of the pathogenesis of pediatric HIV infection. At present, the primary research interests of Dr. Soudeyns are focused on chronic viral infections, notably HIV‐AIDS and hepatitis C. With the support of CIHR and other major funding agencies, his team is pursuing investigations on the pathogenesis of hepatitis C in pregnancy and childhood, on transmission of hepatitis C virus (HCV) from mother to child, and on long‐term remission of HIV infection in children and adolescents. The ultimate goal of this research program is to improve the clinical care of women suffering from hepatitis C, to prevent mother‐to‐child HCV transmission, and to understand whether early treatment initiation in HIV‐infected children can lead to durable, drug‐free remission. Results from this research could open the door to the development of novel practices in the management of HIV and HCV infections in women and children.


This is a free lecture and is open to the public. The lectures are geared towards researchers, clinicians, students and hospital staff.

Eventbrite - Forefront Lectures

For more information, please contact education@cfenet.ubc.ca / local 66255



Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)